Patent details

EP1292326 Title: USE OF INACTIVE CLN2 PROENZYME FOR TREATING LINCL

Basic Information

Publication number:
EP1292326
PCT Application Number:
PCT/US/2001/015386
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP019373372
PCT Publication Number:
WO/2001/085200
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF INACTIVE CLN2 PROENZYME FOR TREATING LINCL
French Title of Invention:
UTILISATION DE CLN2 SOUS FORME DE PROENZYME INACTIVE POUR LE TRAITEMENT DE LINCL
German Title of Invention:
VERWENDUNG VON INAKTIVES CLN2 PROENZYM ZUR BEHANDLUNG VON LINCL
SPC Number:

Dates

Filing date:
11/05/2001
Grant date:
25/04/2007
EP Publication Date:
25/04/2007
PCT Publication Date:
15/11/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
19/03/2003
EP B1 Publication Date:
25/04/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/05/2007
Expiration date:
11/05/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/05/2001
 
 

Name:
UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY
Address:
335 George Street, P.O. Box 3200, New Brunswick, NJ 08901, United States (US)

Inventor

Name:
LOBEL Peter
Address:
United States (US)

Priority

1

Priority Number:
203407 P
Priority Date:
11/05/2000
Priority Country:
United States (US)

2

Priority Number:
852918
Priority Date:
10/05/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/48;
Filing date Document type Number of pages